Citations

Clear

6413 citation(s) found for "Wu, Christopher".

Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis.
Zanelli, Eric , Krco, Christopher J., Baisch, Jeanine , Cheng, S, David, C S, Cheng, S

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 93 | Issue: 5 | Pages: 1814-1819

10.1073/pnas.93.5.1814 | PMID 8700841 Get It

The major histocompatibility complex class II genes play an important role in the genetic predisposition to many autoimmune diseases. In the case of rheumatoid arthritis (RA), the human leukocyte antigen (HLA)-DRB1 locus has been implicated in the disease predisposition. The "shared epitope" hypothesis predicts that similar motifs within the third hypervariable (HV3) regions of some HLA-DRB1 alleles are responsible for the class II-associated predisposition to RA. Using a line of transgenic mice expressing the DQB1*0302/DQA1*0301 (DQ8) genes in the absence of endogenous mouse class II molecules, we have analyzed the antigenicity of peptides covering the HV3 regions of RA-associated and nonassociated DRB1 molecules. Our results show that a correlation exists between proliferative response to peptides derived from the HV3 regions of DRB1 chains and nonassociation of the corresponding alleles with RA predisposition. While HV3 peptides derived from nonassociated DRB1 molecules are highly immunogenic in DQ8 transgenic mice, all the HV3 peptides derived from RA-associated DRB1 alleles fail to induce a DQ8-restricted T-cell response. These data suggest that the role of the "shared epitope" in RA predisposition may be through the shaping of the T-cell repertoire.
αβ T cell receptor interactions with syngeneic and allogeneic ligands: Affinity measurements and crystallization
Tallquist, Michelle D. , Pease, Larry R. , Brunmark, Anders, Degano, Massimo , Stura, E.A. , Peterson, Per A., Wilson, Ian A. , García, K. Christopher , Scott, Christopher A. , Teyton, Luc

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 94 | Issue: 25 | Pages: 13838-13843

10.1073/pnas.94.25.13838 | PMID 9391114 Get It

Cellular immunity is mediated by the interaction of an αβ T cell receptor (TCR) with a peptide presented within the context of a major histocompatibility complex (MHC) molecule. Alloreactive T cells have αβ TCRs that can recognize both self- and foreign peptide–MHC (pMHC) complexes, implying that the TCR has significant complementarity with different pMHC. To characterize the molecular basis for alloreactive TCR recognition of pMHC, we have produced a soluble, recombinant form of an alloreactive αβ T cell receptor in Drosophila melanogaster cells. This recombinant TCR, 2C, is expressed as a correctly paired αβ heterodimer, with the chains covalently connected via a disulfide bond in the C-terminal region. The native conformation of the 2C TCR was probed by surface plasmon resonance (SPR) analysis by using conformation-specific monoclonal antibodies, as well as syngeneic and allogeneic pMHC ligands. The 2C interaction with H-2K b -dEV8, H-2K bm3 -dEV8, H-2K b -SIYR, and H-2L d -p2Ca spans a range of affinities from K d = 10 −4 to 10 −6 M for the syngeneic (H-2K b ) and allogeneic (H-2K bm3 , H-2L d ) ligands. In general, the syngeneic ligands bind with weaker affinities than the allogeneic ligands, consistent with current threshold models of thymic selection and T cell activation. Crystallization of the 2C TCR required proteolytic trimming of the C-terminal residues of the α and β chains. X-ray quality crystals of complexes of 2C with H-2K b -dEV8, H-2K bm3 -dEV8 and H-2K b -SIYR have been grown.
Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”
Aquino, Christopher, Armour, Duncan, Berman, Judd, Birkemo, Larry S., Carr, Robin A. E., Croom, Dallas K., Dezube, Milana, Dougherty, R. W., Ervin, Gregory N., Grizzle, Mary K., Head, Julie E., Hirst, Gavin C. , James, Michael K. , Johnson, Michael F., Queen, Kennedy L., Rimele, Thomas J., Smith, David Norman , Sugg, Elizabeth E., Miller, Laurence J.

Mayo Clinic

Journal of Medicinal Chemistry | July 26, 2002 | Volume: 39 | Issue: 2 | Pages: 562-569

10.1021/jm950626d | PMID 8558528 Get It